Global Hydronephrosis Market, By Type (Unilateral and Bilateral), Diagnosis (Imaging and Laboratory Tests), Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy and Others), Indication (Intrinsic and Extrinsic), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights of Hydronephrosis Market
Data Bridge Market Research analyses that the hydronephrosis market will exhibit a CAGR of around 9.64% for the forecast period of 2022-2029. Rising prevalence of chronic disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced IT healthcare technologies, rising geriatric population base around the globe and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of hydronephrosis market.
Hydronephrosis is a medical condition wherein the patient suffers swollen kidney. The swollen kidney is a result of abnormal drainage of urine from the kidney to the bladder. Hydronephrosis has become a major problem across the globe.
Upsurge in the cases of surgeries for kidney related disorders is one of the major factors fostering the growth of the market. Effective cost of treatment is another market growth determinant. Ever- rising technological advancement and innovation of new instruments and surgical procedures, poor lifestyle choice and growing consumption of alcoholic beverages are other important factors that will further generate lucrative market growth opportunities.
However, lack of awareness about the diseases and treatment will derail the market growth rate. Also, dearth of skilled medical professionals and research analysts and dearth of a favourable reimbursement scenario in the developing and underdeveloped economies will further pose challenges for the market. Further, lack of a strong healthcare IT infrastructure in the underdeveloped economies and developing economies will also hamper the market growth rate.
This hydronephrosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hydronephrosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hydronephrosis Market Scope and Market Size
The hydronephrosis market is segmented on the basis of type, diagnosis, treatment, and indication. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the hydronephrosis market is segmented into unilateral and bilateral.
- Based on diagnosis, the hydronephrosis market is segmented into laboratory test and imaging. Imaging is further segmented into CT-scans, ultrasound, intravenous pyelography, KUB X-rays, and others. Laboratory test is sub segmented into urinanalysis, complete blood count (CBC), electrolyte analysis, and others.
- On the basis of treatment, the hydronephrosis market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.
- Based on indication, the hydronephrosis market is segmented into intrinsic and extrinsic.
Hydronephrosis Market Country Level Analysis
The hydronephrosis market is analysed and market size insights and trends are provided by country, type, diagnosis, treatment, and indication as referenced above.
The countries covered in the hydronephrosis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America and Europe dominate the hydronephrosis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, high spending on healthcare, increase in the prevalence of kidney related disorders, presence of key players in this region, and introduction of technologically advanced products in the region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector, rising geriatric population base especially in emerging economies such as India and China and rising personal disposable income.
The country section of the hydronephrosis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The hydronephrosis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hydronephrosis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hydronephrosis market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Hydronephrosis Market Share Analysis
The hydronephrosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hydronephrosis market.
Some of the major players operating in the hydronephrosis market report are NephroGenex, Inc., American Renal Associates, Phraxis, Inc., Allergan, Amgen Inc., Anthem Bio Pharma, Sanofi, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Stryker, Zimmer Biomet, Smith & Nephew plc, Promega Corporation., Sigma-Aldrich Co., Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc., among others.
SKU-